Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
AdAlta Ltd. ( (AU:1AD) ) just unveiled an update.
AdAlta Limited has completed the issuance of 201,666,666 fully paid ordinary shares at a price of $0.0018 per share. This issuance is part of the company’s funding arrangements with Meurs Group, aimed at addressing outstanding subscription amounts. The shares were issued without disclosure under Part 6D.2 of the Corporations Act, and the company has confirmed compliance with relevant legal provisions. This move is expected to strengthen AdAlta’s financial position and support its ongoing operations in the biotechnology sector.
More about AdAlta Ltd.
AdAlta Limited is a biotechnology company listed on the Australian Securities Exchange (ASX: 1AD). The company specializes in the development of novel therapeutic products, focusing on innovative treatments for diseases with unmet medical needs.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$8.45M
For detailed information about 1AD stock, go to TipRanks’ Stock Analysis page.